FDLI is pleased to invite members to a virtual “Author Happy Hour” to discuss the Update magazine article, “Bad News for Device Sponsors: Panel Meetings were Already Going the Way of the Homework Assignment, and COVID Might ‘Put the Nail in the Coffin.’” Join Hogan Lovells US LLP author Kristin Zielinski Duggan and your peers in the food and drug law community to discuss FDA’s advisory panel meetings to review new medical devices, the shift to written responses by outside experts and virtual panels, and the subsequent impacts to manufacturers. Be prepared to ask the author questions and engage in a dialogue on these and other topics presented in the article, all while enjoying your favorite beverage. This member-only benefit will be limited to twenty attendees to encourage active dialogue in a virtual setting.
Authors and Article
Kristin Zielinski Duggan, Counsel, Hogan Lovells US LLP Sandra Milena McCarthy, Associate, Hogan Lovells US LLP
KRISTIN ZIELINSKI DUGGAN is a counsel in Hogan Lovells’ Medical Device and Technology Regulatory practice based in Washington, D.C. For over 20 years, she has been counseling cutting-edge medical device companies, including assisting with preclinical and clinical programs, preparing marketing submissions, planning for advisory panels, and appealing agency decisions.
SANDRA MILENA MCCARTHY is an associate in Hogan Lovells’ Medical Device and Technology practice based in Washington, D.C. She provides practical insight and advice to companies throughout the medical device product life cycle and those seeking to streamline regulatory approvals.